Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Accumulated Expenses (2022 - 2023)

Historic Other Accumulated Expenses for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q4 2023 value amounting to $1.0 million.

  • Day One Biopharmaceuticals' Other Accumulated Expenses rose 48156.42% to $1.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year increase of 48156.42%. This contributed to the annual value of $1.0 million for FY2023, which is 48156.42% up from last year.
  • According to the latest figures from Q4 2023, Day One Biopharmaceuticals' Other Accumulated Expenses is $1.0 million, which was up 48156.42% from $179000.0 recorded in Q4 2022.
  • Day One Biopharmaceuticals' 5-year Other Accumulated Expenses high stood at $1.0 million for Q4 2023, and its period low was $179000.0 during Q4 2022.